{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:23:20Z","timestamp":1781173400366,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902132"],"award-info":[{"award-number":["81902132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY075"],"award-info":[{"award-number":["2022KY075"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.tube.2022.102256","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T12:39:10Z","timestamp":1662554350000},"page":"102256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5284-7797","authenticated-orcid":false,"given":"Yu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tube.2022.102256_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrmicro.2018.8","article-title":"Ecology and evolution of Mycobacterium tuberculosis","volume":"16","author":"Gagneux","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2022.102256_bib2","series-title":"Global tuberculosis report","author":"World Health Organization WHO","year":"2021"},{"issue":"10","key":"10.1016\/j.tube.2022.102256_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a Re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.tube.2022.102256_bib4","volume":"2","author":"Pai","year":"2016","journal-title":"Tubercul. Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.tube.2022.102256_bib5","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","article-title":"Tuberculosis: advances and challenges in development of new diagnostics and biomarkers","volume":"18","author":"Walzl","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.tube.2022.102256_bib6","first-page":"170","article-title":"The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB)","volume":"111","author":"Zellweger","year":"2020","journal-title":"Med Lav"},{"key":"10.1016\/j.tube.2022.102256_bib7","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2019.01.048","article-title":"Tuberculin skin test - outdated or still useful for Latent TB infection screening?","volume":"80S","author":"Gualano","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.tube.2022.102256_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00408-016-9872-5","article-title":"Interferon-gamma release assays for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"194","author":"Lu","year":"2016","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.tube.2022.102256_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jinf.2020.09.032","article-title":"Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: a systematic review","volume":"81","author":"Sudbury","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2022.102256_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.745592","article-title":"Differential diagnosis of latent tuberculosis infection and active tuberculosis: a key to a successful tuberculosis control strategy","volume":"12","author":"Gong","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2022.102256_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tube.2018.08.006","article-title":"Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection","volume":"112","author":"Balcells","year":"2018","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.tube.2022.102256_bib12","article-title":"Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.tube.2022.102256_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cyto.2008.05.002","article-title":"Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF","volume":"43","author":"Mueller","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.tube.2022.102256_bib14","unstructured":"Sun Q et al: Potential role for Mycobacterium tuberculosis specific IL-2 and IFN-\u03b3 responses in discriminating between latent infection and active disease after long-term stimulation. (1932-6203 (Electronic))."},{"key":"10.1016\/j.tube.2022.102256_bib15","unstructured":"Kumar NP et al: Diminished plasma levels of common \u03b3-chain cytokines in pulmonary tuberculosis and reversal following treatment. (1932-6203 (Electronic))."},{"key":"10.1016\/j.tube.2022.102256_bib16","unstructured":"Domingo-Gonzalez R et al: Cytokines and chemokines in Mycobacterium tuberculosis infection. LID - 10.1128\/microbiolspec.TBTB2-0018-2016 [doi]. (2165-0497 (Electronic))."},{"key":"10.1016\/j.tube.2022.102256_bib17","unstructured":"Park MK et al: The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. (0022-1767 (Print))."},{"issue":"1","key":"10.1016\/j.tube.2022.102256_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47923-w","article-title":"Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: a meta-analysis","volume":"9","author":"Qiu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2022.102256_bib19","unstructured":"Kabeer BS et al: IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. (1471-2334 (Electronic))."},{"key":"10.1016\/j.tube.2022.102256_bib20","unstructured":"Taub DD et al: Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. (0021-9738 (Print))."},{"key":"10.1016\/j.tube.2022.102256_bib21","unstructured":"Bacon KB et al: Activation of dual T cell signaling pathways by the chemokine RANTES. (0036-8075 (Print))."},{"key":"10.1016\/j.tube.2022.102256_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tube.2018.05.004","article-title":"IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring","volume":"111","author":"Zhao","year":"2018","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.tube.2022.102256_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2018.10.017","article-title":"Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection","volume":"78","author":"Luo","year":"2019","journal-title":"J Infect"},{"issue":"10181","key":"10.1016\/j.tube.2022.102256_bib24","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"Furin","year":"2019","journal-title":"Tuberculosis. The Lancet"},{"issue":"6","key":"10.1016\/j.tube.2022.102256_bib25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.smim.2014.09.011","article-title":"Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis","volume":"26","author":"Etna","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.tube.2022.102256_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tube.2017.07.013","article-title":"Multiplex analysis of plasma cytokines\/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants","volume":"107","author":"Yao","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2022.102256_bib27","unstructured":"Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. (0741-5400 (Print))."},{"issue":"1","key":"10.1016\/j.tube.2022.102256_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1186\/s12879-019-4466-5","article-title":"Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis","volume":"19","author":"Qiu","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.tube.2022.102256_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jinf.2014.02.008","article-title":"High urine IP-10 levels associate with chronic HCV infection","volume":"68","author":"Petrone","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2022.102256_bib30","unstructured":"Villar-Hern\u00e1ndez R et al: Use of IFN-\u03b3 and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases. (1532-2742 (Electronic))."},{"issue":"10","key":"10.1016\/j.tube.2022.102256_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apm.12583","article-title":"Evaluation of a whole-blood chemiluminescent immunoassay of IFN-gamma, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients","volume":"124","author":"Liang","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.tube.2022.102256_bib32","unstructured":"Sadek MI et al: Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. (1044-1549 (Print))."},{"key":"10.1016\/j.tube.2022.102256_bib33","unstructured":"Kouhpayeh HR et al: CCL5 rs2107538 polymorphism increased the risk of tuberculosis in a sample of Iranian population. (1214-6994 (Print))."},{"issue":"4","key":"10.1016\/j.tube.2022.102256_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00759-17","article-title":"Potential immunological biomarkers for detection of Mycobacterium tuberculosis infection in a setting where M. tuberculosis is endemic, Ethiopia","volume":"86","author":"Teklu","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2022.102256_bib35","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3389\/fimmu.2019.02350","article-title":"IL-2 restores T-cell dysfunction induced by persistent Mycobacterium tuberculosis antigen stimulation","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2022.102256_bib36","unstructured":"Biselli R et al: Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. (1469-0691 (Electronic))."},{"key":"10.1016\/j.tube.2022.102256_bib37","unstructured":"Goletti D et al: Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. (0022-1899 (Print))."},{"key":"10.1016\/j.tube.2022.102256_bib38","unstructured":"Millington KA et al: Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. (0022-1767 (Print))."},{"key":"10.1016\/j.tube.2022.102256_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fcimb.2017.00457","article-title":"Application of ImmunoScore model for the differentiation between active tuberculosis and latent tuberculosis infection as well as monitoring anti-tuberculosis therapy","volume":"7","author":"Zhou","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.tube.2022.102256_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tube.2017.04.005","article-title":"Chemokines additional to IFN-gamma can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype","volume":"105","author":"Nonghanphithak","year":"2017","journal-title":"Tuberculosis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979222000932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979222000932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:47:40Z","timestamp":1761468460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979222000932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"alternative-id":["S1472979222000932"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2022.102256","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2022.102256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102256"}}